Cargando…

Pattern of bone metastasis in patients with nonsmall cell lung cancer

Detalles Bibliográficos
Autores principales:	Miyazaki, Kunihiko, Shiozawa, Toshihiro, Yamada, Hideyasu, Tamura, Tomohiro, Satoh, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196660/ https://www.ncbi.nlm.nih.gov/pubmed/30416600 http://dx.doi.org/10.4103/atm.ATM_237_18

Ejemplares similares

Distant organ metastasis patterns in lung cancer patients with pancreatic metastasis – a cluster analysis
por: Okauchi, Shinichiro, et al.
Publicado: (2022)

Polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion
por: Okauchi, Shinichiro, et al.
Publicado: (2020)

Comparison between FDG-PET/CT and bone scan in bone metastasis from NSCLC
por: Tamura, Tomohiro, et al.
Publicado: (2014)

Microbiological spectrum of pneumonia in patients with lung cancer
por: Tamura, Tomohiro, et al.
Publicado: (2016)

Ossification and increased bone mineral density with zoledronic acid in a patient with lung adenocarcinoma: A case report
por: KURISHIMA, KOICHI, et al.
Publicado: (2014)

Hematogenous muscular metastasis of NSCLC in FDG-PET/CT
por: Satoh, Hiroaki, et al.
Publicado: (2015)

Blood-patch pleurodesis for pneumothorax in lung fibrosis due to progressive systemic sclerosis: A case report
por: KAGOHASHI, KATSUNORI, et al.
Publicado: (2014)

A long-term responding epidermal growth factor receptor mutated non-small cell lung cancer patient with extremely high mutation allele frequency
por: Miyazaki, Kunihiko, et al.
Publicado: (2022)

Bone marrow micrometastasis in nonsmall cell lung cancer: A new prognostic marker?
por: Barbetakis, Nikolaos, et al.
Publicado: (2019)

Response to Afatinib in a Common EGFR-Mutated Lung Adenocarcinoma with a Very Rare Combination of Compound Mutations
por: Satoh, Hiroaki, et al.
Publicado: (2022)

Superficial-type endobronchial metastases from colon cancer: A case report
por: KURISHIMA, KOICHI, et al.
Publicado: (2014)

Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2017)

A rare case of hyperprogression of nonsmall cell lung cancer in a patient on atezolizumab therapy
por: Kollimuttathuillam, Sudarsan Vishnu, et al.
Publicado: (2020)

Sarcoidosis presenting with acute respiratory distress syndrome
por: Tamura, Tomohiro, et al.
Publicado: (2016)

Decortication of empyema
por: Ohara, Gen, et al.
Publicado: (2016)

Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2014)

Small cell lung cancer with endobronchial growth: A case report
por: KURISHIMA, KOICHI, et al.
Publicado: (2013)

Thyroid Metastasis from Nonsmall Cell Lung Cancer
por: Namad, Tariq, et al.
Publicado: (2013)

Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence
por: Kaur, Harpreet, et al.
Publicado: (2016)

Prognostic value of serum high‐density lipoprotein cholesterol elevation in nonsmall cell lung cancer patients receiving radical surgery
por: Luo, Fan, et al.
Publicado: (2020)

Relationship between lung function and inhalation devices for LAMA/LABA therapy for chronic obstructive pulmonary disease
por: Yamada, Hideyasu, et al.
Publicado: (2017)

Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
por: Ma, Yuxiang, et al.
Publicado: (2021)

Peritoneal and meningeal relapse from lung adenocarcinoma after a response to gefitinib: A case report
por: KURISHIMA, KOICHI, et al.
Publicado: (2013)

Superiority of tiotropium plus olodaterol in comparison with salmeterol plus fluticasone
por: Tamura, Tomohiro, et al.
Publicado: (2016)

Isolated solitary brain metastasis as a relapse of small cell lung cancer
por: SAKURAI, HIROFUMI, et al.
Publicado: (2013)

Capmatinib-Associated Pseudoacute Kidney Injury in Nonsmall Cell Lung Cancer
por: Sandoval, Leticia, et al.
Publicado: (2023)

Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease
por: Satoh, Hiroaki, et al.
Publicado: (2022)

Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
por: Hiraki, Takao, et al.
Publicado: (2014)

Comment on: “Handgrip weakness, low fat‐free mass, and overall survival in nonsmall cell lung cancer treated with curative‐intent radiotherapy" by Burtin et al.
por: Shafieesabet, Azadeh, et al.
Publicado: (2020)

Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
por: Satoh, Hiroaki, et al.
Publicado: (2022)

Solitary fibular metastasis from nonsmall cell lung carcinoma
por: Akram, Mohammad, et al.
Publicado: (2017)

The pattern of bone involvement, management, and outcomes in patients with nonsmall cell lung cancer: A retrospective study
por: Jazieh, Abdulrahman M., et al.
Publicado: (2018)

Incremental low doses of amrubicin for the treatment of bone marrow metastasis in small cell lung cancer
por: Asai, Nobuhiro, et al.
Publicado: (2013)

Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis
por: de Bessa, Camila Martins, et al.
Publicado: (2022)

Rinsing of oropharynx and storage place of respiratory medicine inhaler: A cross‐sectional audit
por: Okauchi, Shinichiro, et al.
Publicado: (2019)

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)
por: Kobayashi, Kunihiko, et al.
Publicado: (2013)

Cluster analysis of deterioration sites after first-line epidermal growth factor receptor-tyrosine kinase inhibitor in epidermal growth factor receptor mutated non-small cell lung cancer
por: Okauchi, Shinichiro, et al.
Publicado: (2022)

Skeletal-related events and overall survival of patients with bone metastasis from nonsmall cell lung cancer – A retrospective analysis
por: Kong, Pengyu, et al.
Publicado: (2017)

Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario
por: Thakur, Sayanta, et al.
Publicado: (2020)

Long‐term outcomes of high‐dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer
por: Ohnishi, Kayoko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ap93iao5m04l7trgk6qk5pl90